Literature DB >> 23902694

A weighting analogue to pair matching in propensity score analysis.

Liang Li, Tom Greene.   

Abstract

Propensity score (PS) matching is widely used for studying treatment effects in observational studies. This article proposes the method of matching weights (MWs) as an analog to one-to-one pair matching without replacement on the PS with a caliper. Compared with pair matching, the proposed method offers more efficient estimation, more accurate variance calculation, better balance, and simpler asymptotic analysis. A statistical test for the misspecification of the PS model is proposed for balance checking purposes. An augmented version of the MW estimator is developed that has the double robust property, that is, the estimator is consistent, if either the outcome model or the PS model is correct. The proposed method is studied in simulations and illustrated through a real data example.

Mesh:

Year:  2013        PMID: 23902694     DOI: 10.1515/ijb-2012-0030

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  77 in total

1.  A tool for empirical equipoise assessment in multigroup comparative effectiveness research.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-27       Impact factor: 2.890

2.  Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.

Authors:  Houchen Lyu; Sizheng S Zhao; Kazuki Yoshida; Sara K Tedeschi; Chang Xu; Sagar U Nigwekar; Benjamin Z Leder; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

3.  Matching Weights to Simultaneously Compare Three Treatment Groups: Comparison to Three-way Matching.

Authors:  Kazuki Yoshida; Sonia Hernández-Díaz; Daniel H Solomon; John W Jackson; Joshua J Gagne; Robert J Glynn; Jessica M Franklin
Journal:  Epidemiology       Date:  2017-05       Impact factor: 4.822

4.  Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

Authors:  Steffen Ventz; Albert Lai; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

5.  Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Jessica M Franklin; Til Stürmer; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2019-03-01       Impact factor: 4.897

6.  Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.

Authors:  Yuan Yuan; Lingxiang Liu; Hu Chen; Yumeng Wang; Yanxun Xu; Huzhang Mao; Jun Li; Gordon B Mills; Yongqian Shu; Liang Li; Han Liang
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

7.  Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors:  Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

8.  Functional Outcome After Intracranial Pressure Monitoring for Children With Severe Traumatic Brain Injury.

Authors:  Tellen D Bennett; Peter E DeWitt; Tom H Greene; Rajendu Srivastava; Jay Riva-Cambrin; Michael L Nance; Susan L Bratton; Desmond K Runyan; J Michael Dean; Heather T Keenan
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

9.  An Algorithm for Creating Virtual Controls Using Integrated and Harmonized Longitudinal Data.

Authors:  William B Hansen; Shyh-Huei Chen; Santiago Saldana; Edward H Ip
Journal:  Eval Health Prof       Date:  2018-05-03       Impact factor: 2.651

10.  First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.

Authors:  Ya-Chen Tina Shih; Ying Xu; Wenli Dong; Fabrice Smieliauskas; Sharon Giordano; Yu Shen
Journal:  Breast Cancer Res Treat       Date:  2014-02-21       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.